Latest News about GSK
Recent news which mentions GSK
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
February 20, 2022
From Benzinga
Moderna Adds Three New mRNA-Based Development Programs To Its Pipeline
February 18, 2022
From Benzinga
Want To Collect $200 Every Month? Invest $49,334 in These 3 Stocks
February 18, 2022
From Motley Fool
GSK Halts Late-Stage RSV Vaccine Trial In Pregnant Women
February 18, 2022
From Benzinga
The Daily Biotech Pulse: Regeneron-Sanofi Halt Late-Stage Dupixent Study, Agios Gets FDA Nod, Safety Scare For GSK's RSV Vaccine, Shockwave Jumps On Earnings
February 18, 2022
From Benzinga
After Falling 67% in 1 Year, Is 23andMe Undervalued?
February 16, 2022
From Motley Fool
Inside Gilead's Lackluster $7.2 Billion Q4 Earnings
February 16, 2022
From Motley Fool
The Best Russell 2000 Stocks to Buy Before they Rebound
February 15, 2022
From InvestorPlace
4 Green Flags for 23andMe's Future
February 15, 2022
From Motley Fool
Tracking Gilead's 4 Big Stories and a Lawsuit in 2022
February 15, 2022
From Motley Fool
From MarketWatch
3 Biotech Stocks That Are too Cheap to Ignore
February 10, 2022
From Motley Fool
From Benzinga
Why Are Seagen Shares Sinking Today?
February 10, 2022
From Benzinga
Glaxo's Q4 Pharma Sales Jump 20% Boosted By COVID-19 Treatment; Prepares For Spin-Off
February 09, 2022
From Benzinga
From MarketWatch
Earnings Scheduled For February 9, 2022
February 09, 2022
From Benzinga
Immunome Shares Seesaw After COVID-19 Antibody Cocktail Works Against Live Omicron Virus
February 08, 2022
From Benzinga
‘You will not believe what I’ve just found.’ Inside the ivermectin saga: a hacked password, mysterious websites and faulty data
February 07, 2022
From MarketWatch
COVID-19 treatments raked in billions of dollars in 2021. How will they do this year?
February 04, 2022
From MarketWatch
From Benzinga
From Benzinga
Gilead earnings slammed by legal settlement, stock falls
February 01, 2022
From MarketWatch
FDA Approves First Injectable For HIV Pre-Exposure Prevention - GSK, Pfizer Backed Treatment
February 01, 2022
From Benzinga
From Motley Fool
10 Stocks to Buy That Could Make You a Millionaire in 2022
January 26, 2022
From InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
